Condensed Consolidated Statements of Changes in Redeemable Convertible Preferred Shares and in Stockholders’ Equity (Capital Deficiency) (Unaudited) (Parentheticals) - USD ($) $ in Thousands |
3 Months Ended | ||||
|---|---|---|---|---|---|
Mar. 31, 2024 |
Jun. 30, 2023 |
Mar. 31, 2023 |
|||
| Statement of Stockholders' Equity [Abstract] | |||||
| Issuance of common stock under open market sales agreement, net of issuance costs | [1] | $ 1 | |||
| Issuance of Common Stock and warrants under February 2023 PIPE, net of issuance costs | [1] | $ 157 | $ 176 | ||
| |||||
| X | ||||||||||
- Definition Issuance of common stock and warrants under february 2023 PIPE, net of issuance costs. No definition available.
|
| X | ||||||||||
- Definition The cash inflow from additional borrowings, net of cash paid to third parties in connection with debt origination. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|